Italian Authorities Investigate Misleading Ads by BAT and Amazon

Apr.18.2023

Italian Authorities Investigate Misleading Ads by BAT and Amazon

Italian authorities investigate misleading ads for BAT's glo hyper X2 on Amazon for potential health risks.

On April 18th, according to a report by Market Watch, the Italian Competition Authority (AGCM) launched an investigation into British American Tobacco (BAT) and Amazon, citing claims that the two companies have been providing misleading information in their advertising for new heated tobacco devices.

The Italian competition watchdog announced that the advertising campaign for the glo hyper X2 product, owned by British American Tobacco, inaccurately suggested that the product is nicotine-free. The advertisement was disseminated on Amazon, and could potentially pose health risks to some consumers, particularly minors.

Currently, neither British American Tobacco nor Amazon have responded to the issue.

Further reading:

British American Tobacco responds to 2FIRSTS: Testing of disposable e-cigarettes in the UK is a valid concern.

British and American tobacco companies are suspected of initiating an anti-ban movement against electronic cigarettes in Australia. The related videos have been removed.

The IBVTA says that any harm reduction claims made by BAT should be questioned.

Legal Expert Op-Ed: BAT Cannot Serve as Enforcement Police for E-Cigarettes

BAT has launched a pop-up store called "Glo studio" in South Korea to kick off a new product experience event.

References:

Amazon and British American Tobacco are under investigation in Italy for their promotion of heated tobacco devices through advertising.

#Legislation #Africa #Uganda #British American Tobacco (BAT)

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes

Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes

Malaysia plans to implement a ban or restrictions on e-cigarettes and vaping products as early as mid-2026 and no later than year-end. The head of Philip Morris Malaysia and Singapore said the government should look to Japan’s approach of regulating and taxing different tobacco and nicotine products differently, warning that an outright ban could push demand into illicit channels.

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.

PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries

PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries

At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.

PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April

PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April

Japan will adjust tobacco taxes from April 1, 2026, prompting Philip Morris International (PMI) to lift prices for its IQOS ILUMA tobacco sticks TEREA and SENTIA. Both products are set to rise by 40 yen per pack (about $0.3).

Jan.21 by 2FIRSTS.ai

MEPs seek Commission answers over EU trade officials’ contacts with PMI

MEPs seek Commission answers over EU trade officials’ contacts with PMI

POLITICO reports that five members of the European Parliament’s health committee want to invite the European Commission to answer questions about its contacts with Philip Morris International (PMI), following a POLITICO and The Examination investigation into extensive meetings between EU trade officials and tobacco lobbyists.

Jan.15 by 2FIRSTS.ai

FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty

FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty

FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.

Related Topics

News

Related Read

Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes

Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries

PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries

PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April

PMI’s Japan unit to raise IQOS ILUMA stick prices; TEREA and SENTIA to increase from April

MEPs seek Commission answers over EU trade officials’ contacts with PMI

MEPs seek Commission answers over EU trade officials’ contacts with PMI

FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty

FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty